Abstracts
Résumé
Cet article examine l’apparition du terme biomédecine et le débat corrélatif sur les relations entre le normal et le pathologique. Au lieu de voir la biomédecine comme une simple application de connaissances biologiques à la médecine, voire un va-et-vient entre la clinique et le laboratoire, les auteurs proposent la notion de plate-forme biomédicale où la clinique et le laboratoire s’intriquent et se réalignent, d’une manière toujours remise en question au gré des innovations techniques et de l’automatisation croissante des opérations moléculaires. Les exemples utilisés pour illustrer ce processus sont empruntés à la biologie des leucémies.
Summary
The article examines the debates surrounding the emergence of the term biomedicine, with a particular focus on the relation between the pathological and the normal. The authors reject simplistic definitions of biomedicine as a one-way street leading to the application of medical knowledge to medicine, or even as a two-way street characterized by iterative exchanges between the clinic and the laboratory. Rather, the authors introduce the notion of a biomedical platform as the site where the clinic and the laboratory intermingle and are realigned in connection with the ongoing process of medical innovation and the increasing automation of molecular procedures. The examples used in the article are drawn mainly from the field of onco-hematology.
Appendices
Références
- 1. Tubiana M. Histoire de la pensée médicale. Les chemins d’Esculape. Paris: Flammarion, 1995: 713 p.
- 2. Gaudillière JP. Inventer la biomédecine. La France, l’Amérique et la production des savoirs du vivant (1945-1965). Paris: La Découverte, 2002: 392 p.
- 3. Ahrens EH. The crisis in clinical research: Overcoming institutional obstacles. New York: Oxford University Press, 1992, 236 p.
- 4. Picard JF. De la médecine expérimentale (1865) à l’INSERM (1964). In: Debru C, Gayon J, Picard JF, ed. Les sciences biologiques et médicales en France, 1920-1950. Paris: CNRS, 1994: 329-44.
- 5. Dill KA. Strengthening biomedicine’s roots. Nature 1999; 400: 309-10.
- 6. Schechter AN. Medicine and biology are more than biomedicine. Nature 1999; 401: 424.
- 7. Schechter AN. The crisis in clinical research: Endangering the half-century National institutes of health consensus. JAMA 1998; 280: 1440-2.
- 8. Löwy I. Between bench and bedside. Science, healing, and interleukin-2 in a cancer ward. Cambridge, Mass.: Harvard University Press, 1996: 370 p.
- 9. Sinding C. Le clinicien et le chercheur. Des grandes maladies de carence à la médecine moléculaire, 1880-1980. Paris: Presses Universitaires de France, 1991: 284 p.
- 10. Feinstein AR. The crisis in clinical research. Bull Hist Med 1995; 69: 288-91.
- 11. Chabner BA, Boral AL, Multani P. Translational research: Walking the bridge between idea and cure. Seventeenth Bruce F. Cain memorial award lecture. Cancer Res 1998; 58: 4211-6.
- 12. Thomson AL. Half a century of medical research. London: HMSO, 1973-1975.
- 13. Rothstein WG. American medical schools and the practice of medicine: A history. New York: Oxford University Press, 1987: 408p.
- 14. Geiger RL. Science and the university. In: Krige J, Pestre D, ed. Science in the twentieth century. Amsterdam: Harwood Academic, 1997: 159-74.
- 15. Boot CC. Clinical Research. In: Bynum WF, Porter R, ed. Companion encyclopedia of the history of medicine. Vol. I. London: Routledge, 1993: 205-29.
- 16. Lawrence C. Clinical Research. In: Krige J, Pestre D, ed. Science in the twentieth century. Amsterdam: Harwood Academic, 1997: 439-59.
- 17. Keating P, Cambrosio A. Biomedical platforms. Realigning the normal and the pathological in late-twentieth-century medicine. Cambridge, MA: MIT Press, 2003: 560 p.
- 18. Downey H. Handbook of hematology. Vol. 3. New York: Hafner, 1965.
- 19. Van Dongen JJM, Adriaansen HJ. Immunobiology of leukemia. In: Henderson ES, Lister TA, Greaves MF, ed. Leukemia. 6th ed. Philadelphia: Saunders, 1996: 83-130.
- 20. Canguilhem G. Le normal et le pathologique. Paris: Presses Universitaires de France, 1972, 226 p.
- 21. Whittaker MH, Willman CL. A practical guide to the use of molecular genetic techniques in the diagnosis of lymphoid malignancies. In: Fenoglio-Preiser CM, Willman CL, ed. Molecular diagnostics in pathology. Baltimore: Williams and Wilkins, 1991: 123-48.
- 22. Keating P. Cambrosio A. Real compared to what? diagnosing leukemias and lymphomas. In: Lock M, Young A, Cambrosio A, ed. Living and working with the new medical technologies. Intersections of inquiry. Cambridge, UK: Cambridge University Press, 2000: 103-34.
- 23. Rheinberger HJ. Toward a history of epistemic things. Synthesizing proteins in the test tube. Stanford: Stanford University Press, 1997: 325 p.
- 24. Moulin AM. Le dernier langage de la médecine. Histoire de l’immunologie de Pasteur au sida. Paris: Presses Universitaires de France, 1991; 447 p.
- 25. Raff MC. Cell-surface immunology. Sci Am 1976; 234: 30-9.
- 26. Austoker J. A history of the Imperial cancer research fund, 1902-1986. Oxford: Oxford University Press, 1988: 375 p.
- 27. Keating P, Cambrosio A. The new genetics and cancer. The contributions of clinical medicine in the era of biomedicine. J His Med Allied Sci 2001; 56: 321-52.
- 28. Morange M. Histoire de la biologie moléculaire. Paris: La Découverte, 1994: 358p.
- 29. Keating P, Cambrosio A. Signs, markers, profiles, and signatures: Clinical hematology meets the new genetics (1980-2000). New Genetics and Society 2004; 23 (sous presse).
- 30. Thomas L. Aspects of biomedical science policy. Washington: National academy of sciences - Institute of medicine, 1972: 16 p.
- 31. Lenoir T, Hays M. The Manhattan project for biomedicine. In: Sloan PR, ed. Controlling our destinies. Historical, philosophical, ethical, and theological perspectives on the Human genome project. South Bend, Indiana: University of Notre Dame Press, 2000: 29-62.
- 32. Reiser SJ. Medicine and the reign of technology. Cambridge, UK: Cambridge University Press, 1981: 317 p.
- 33. Keating P, Limoges C, Cambrosio A. The automated laboratory. The generation and replication of work in molecular genetics. In: Fortun M, Mendelsohn E, ed. The Practices of human genetics. Dordrecht: Kluwer, 1999: 125-42.
- 34. Kaufert PA. Screening the Body: The pap smear and the mammogram. In: Lock M, Young A, Cambrosio A, ed. Living and working with the new medical technologies. Intersections of inquiry. Cambridge, UK: Cambridge University Press, 2000: 165-83.
- 35. Bernard J. Summing up. Blood Cells 1980; 6: 499-500.